Post-90s investors watch RXS: How far is the road from a 90% plunge to a rebound by 2026?

RXS experienced a severe crash after its launch in 2025, but can this project, praised as the infrastructure for real asset tokenization, truly rebound in 2026? This article analyzes whether Rexas Finance can achieve a “rebirth from the ashes” from three perspectives: project essence, market prospects, and investment strategies.

Key Highlights

• Price Situation: RXS dropped from a peak of $0.1147 to around $0.0006, a decline of over 99%
• Market Background: Real Asset Tokenization ( RWA ) market is projected to reach $5.6 billion in 2026
• Technical Support: Certified by CertiK, with complete tools like Token Builder, Launchpad, etc.
• Post-90s Opportunities: An extremely undervalued “value depression,” but risks are also extreme
• 2026 Forecast: Conservative $0.22-$0.55, optimistic $5-$10, baseline scenario $2-$3

RXS’s “Darkest Hour”: From Expectation to Disappointment

Price Free Fall

On June 19, 2025, Rexas Finance was listed amid widespread anticipation. However, reality turned into a collective tragedy.

According to public market data, RXS briefly hit $0.1147 on the first day before plunging into an abyss. By January 2026, the price had fallen to $0.0006, shrinking over 99% from its peak. 24-hour trading volume dropped to about $170,000, and market cap evaporated.

This is not just a price decline but a complete destruction of investor confidence.

The Triple Blow Effect

Collective Escape of Presale Arbitrageurs

Investors who bought during the presale at $0.03-$0.20 saw paper gains of up to 8x upon listing. When tokens started unlocking, these early participants chose the most rational decision—taking profits. The massive sell-off pressure instantly caused a sharp decline, creating a fierce downward trend. While such drops are common in crypto projects, RXS’s decline was indeed extraordinary.

Gap Between Promotion and Reality

The market’s promoted $0.25 listing price was 60% higher than the actual listing price, causing a trust crisis. Reddit and Telegram were filled with complaints of being misled, and panic selling ensued.

Invisible Damage from Team Communication

Although Rexas Finance has a complete ecosystem of RWA tools, post-listing social media updates mainly stayed at exchange notices, rarely mentioning technical progress. This communication vacuum further deepened market pessimism.

The Reversal Logic in 2026: The Explosive Period of Real Asset Tokenization

Despite the disappointment in 2025, 2026 could be a pivotal year for RXS. Several factors are brewing for change.

Confirmed Growth in the RWA Market

According to blockchain industry research, the global real asset tokenization market is expected to reach $5.6 billion in 2026. This is not a vague prediction but a trend endorsed by Wall Street giants.

BlackRock CEO explicitly stated in a 2025 investor letter that tokenized assets will become the next frontier in finance. Traditional assets like real estate, art, and commodities are moving onto blockchain, transitioning from concept to reality.

Rexas Finance’s core positioning is as an infrastructure provider in this wave. If the RWA market truly explodes in 2026, RXS as a foundational utility token will directly benefit.

Gradual Clarification of Regulatory Environment

The U.S. Securities and Exchange Commission (SEC) is expected to establish a basic regulatory framework for tokenized assets in 2026. This is a positive signal for the entire Web3 ecosystem.

Clearer regulation means more traditional financial institutions can participate compliantly, greatly expanding potential applications and user base for RWA. For Rexas Finance, a regulator-friendly environment will eliminate many uncertainties.

Practical Application Potential of the Tech Stack

Rexas Finance’s technological accumulation is noteworthy:

• Token Builder: A no-code token creation tool, enabling non-technical asset owners to issue tokens
• Launchpad Platform: Provides decentralized fundraising channels for tokenized projects
• DeFi Ecosystem: Multi-chain trading and yield optimization solutions
• AI Shield: Smart contract security auditing mechanism
• CertiK Certification: Audited by top blockchain security firm

If these tools are adopted by real estate developers, art institutions, or commodities traders in 2026, the practical value of RXS will be validated.

Price Outlook in 2026: Three Scenario Analyses

Conservative Scenario: $0.22-$0.55 range

Assuming Rexas Finance can steadily deliver promised features and gradually attract real users, the price might rebound into this range. This implies a 400-900x increase from current prices but still far below the presale price.

This forecast assumes the project can partially fulfill its promises but faces industry competition constraints.

Neutral Scenario: $2-$3 level

If the RWA market confirms rapid growth in 2026 and Rexas Finance makes breakthroughs in core applications like real estate tokenization, prices could further rise. This requires the project to excel in marketing, ecosystem partnerships, and technical delivery.

Optimistic Scenario: $5-$10 potential

Analysts bullish on the RWA track suggest that if Bitcoin breaks $150,000, driving a bull market, and Rexas Finance successfully launches landmark tokenization projects (such as large commercial real estate or renowned art pieces), RXS could replicate early growth trajectories of projects like Solana or Polygon.

Important Reminder: These forecasts heavily depend on project execution, market environment, and policy changes. Investors must remain rational and cautious.

Substantial Risks and Real Opportunities in RXS Investment

Risks That Must Be Recognized

Uncertainty in Project Delivery

Whether RXS can truly realize large-scale real asset tokenization remains the biggest question. So far, no successful large application case has been seen, which is the core risk.

Intense Competition in the Sector

Competitors like Ondo Finance have stronger institutional backgrounds and regulatory compliance. Rexas Finance must find a unique positioning to stand out.

Liquidity Dilemmas

Extremely low trading volume means any large transaction could trigger significant volatility.

Hidden Investment Opportunities

Extremely Undervalued Assets

Falling from $0.1147 to $0.0006, almost all negative factors have been digested. For investors with high risk tolerance, this could be a “value depression.”

Long-term Industry Development Certainty

Regardless of Rexas Finance’s performance, real asset tokenization remains one of the most promising applications of blockchain technology. This provides fundamental support for RXS’s industry prospects.

Potential for Community Revival

If the team improves communication, rebuilds trust, and delivers 1-2 demonstrative projects, market sentiment could quickly reverse.

Practical Investment Strategies for 2026

Staged Positioning Strategy

Given the high uncertainty, a phased entry approach is recommended:

Phase 1 ( 30% of funds ) Tentative accumulation at current $0.0006-$0.001, testing bottom support

Phase 2 ( 30% of funds ) Add when the project announces major technical progress in Q1-Q2, and price rebounds to $0.005-$0.01

Phase 3 ( 40% of funds ) If the RWA market confirms explosive growth in H2 2026 and price breaks $0.05, add again

Rational Stop-Loss and Take-Profit Settings

• Stop-loss: $0.0003 (50% below current price)
• First Take-Profit: $0.02 (~30x return), realize 30% of holdings
• Second Take-Profit: $0.10 (~160x return), realize 40% of holdings
• Long-term Hold: Keep 30% to target $1+ potential

Information Tracking Checklist

Continuously monitor these signals to judge buy/sell timing:

• Rexas Finance official technical updates frequency
• 24-hour trading volume trend
• Social media sentiment indicators
• News of large institutional cooperation with Rexas
• SEC policies on tokenization regulation

Key Questions for Post-90s Investors

Is RXS still worth entering now?

RXS is in an extremely undervalued state, but risks are also at the extreme. Only suitable for investors with strong risk tolerance who can accept total loss of principal. It is recommended to allocate no more than 5% of your portfolio, viewing it as a “high risk, high return” allocation.

Can it return to the $0.20 presale price in 2026?

Possible but with low probability. The realistic target for 2026 should be in the $0.22-$0.55 range. Returning to the presale price requires perfect market conditions and flawless project execution. Investors should evaluate risk-reward based on current $0.0006 price rather than the $0.20 presale price.

How does RXS differ from other RWA projects?

RXS’s “no-code” Token Builder tool and multi-chain DeFi ecosystem are its features, theoretically lowering tokenization barriers. But compared to competitors like Ondo Finance, Rexas Finance lacks institutional-level compliance background. The disadvantage could also be an advantage—if it attracts small asset owners who don’t follow traditional routes, it might open a differentiated market.

Conclusion

RXS’s performance in 2025 is a textbook case of investment failure, but 2026 could be a turning point for a “rebirth from the ashes.” The potential of the real asset tokenization market is indeed huge, Rexas Finance’s tech stack is relatively complete, and the key lies in whether the vision can truly be realized into usable applications.

For post-90s and other investors, RXS serves as both a warning—reminding us of the cruelty and uncertainty of the crypto market—and an opportunity—to find market-mispriced value during the most pessimistic moments.

If you decide to participate in RXS trading, remember:

1. Invest only what you can afford to lose entirely
2. Conduct thorough independent research (DYOR )
3. Set strict stop-loss levels
4. Continuously track project progress and market signals
5. Assess your own risk tolerance

In the crypto market, risk and opportunity are always two sides of the same coin. The story of RXS in 2026 is worth our ongoing observation.

Disclaimer

This article is for informational purposes only and does not constitute any investment advice. Cryptocurrency investments carry extremely high risks. RXS has already experienced over 90% price decline, and future performance is highly uncertain. Price forecasts in this article are based on public market analysis but do not guarantee accuracy.

Before investing in RXS, conduct thorough independent research, evaluate your risk tolerance, consult professional advisors, understand relevant laws and regulations, and only invest funds you can afford to lose entirely. The author and the publishing platform are not responsible for any losses resulting from the use of this information.